Brokers Issue Forecasts for Danaher’s Q1 Earnings (NYSE:DHR)

Danaher Corporation (NYSE:DHR) – Analysts at Zacks Research cut their Q1 2026 earnings per share (EPS) estimates for Danaher in a research note issued on Tuesday, November 11th. Zacks Research analyst Team now forecasts that the conglomerate will earn $1.98 per share for the quarter, down from their previous forecast of $1.99. The consensus estimate for Danaher’s current full-year earnings is $7.63 per share. Zacks Research also issued estimates for Danaher’s Q3 2026 earnings at $1.97 EPS, FY2026 earnings at $8.32 EPS, Q1 2027 earnings at $2.06 EPS and FY2027 earnings at $9.17 EPS.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.17. The business had revenue of $6.05 billion during the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.Danaher’s revenue was up 4.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.71 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS.

Other analysts have also issued research reports about the company. Rothschild Redb lowered Danaher from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 8th. Royal Bank Of Canada set a $241.00 price target on shares of Danaher in a report on Tuesday, September 2nd. Weiss Ratings restated a “hold (c-)” rating on shares of Danaher in a research note on Wednesday, October 8th. Bank of America dropped their price objective on shares of Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a research note on Monday, September 22nd. Finally, Cowen reissued a “buy” rating on shares of Danaher in a research note on Wednesday, October 22nd. Eighteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $243.39.

Danaher Stock Performance

Danaher stock opened at $215.80 on Wednesday. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. Danaher has a 1-year low of $171.00 and a 1-year high of $258.23. The firm has a market capitalization of $152.43 billion, a PE ratio of 44.49, a price-to-earnings-growth ratio of 3.28 and a beta of 0.81. The firm’s 50 day simple moving average is $204.36 and its 200 day simple moving average is $200.64.

Institutional Investors Weigh In On Danaher

Institutional investors and hedge funds have recently modified their holdings of the company. Generali Investments Management Co LLC lifted its position in shares of Danaher by 8.2% during the 3rd quarter. Generali Investments Management Co LLC now owns 15,020 shares of the conglomerate’s stock valued at $2,978,000 after buying an additional 1,139 shares in the last quarter. Fifth Lane Capital LP acquired a new position in shares of Danaher in the third quarter valued at approximately $298,000. R Squared Ltd increased its position in shares of Danaher by 52.8% in the 3rd quarter. R Squared Ltd now owns 3,757 shares of the conglomerate’s stock valued at $745,000 after purchasing an additional 1,298 shares during the last quarter. Diversify Wealth Management LLC boosted its holdings in shares of Danaher by 8.9% in the 3rd quarter. Diversify Wealth Management LLC now owns 12,148 shares of the conglomerate’s stock valued at $2,600,000 after buying an additional 994 shares in the last quarter. Finally, Hohimer Wealth Management LLC acquired a new position in shares of Danaher in the 3rd quarter valued at $2,218,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Buying and Selling

In other news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. 11.20% of the stock is owned by company insiders.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, October 31st. Shareholders of record on Friday, September 26th were given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Friday, September 26th. Danaher’s payout ratio is 26.39%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.